BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 63 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $835 | +16600.0% | 652 | -83.6% | 0.00% | – |
| Q1 2023 | $5 | +66.7% | 3,972 | +79.2% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 2,217 | -88.0% | 0.00% | – |
| Q3 2022 | $28,000 | +75.0% | 18,537 | +130.4% | 0.00% | – |
| Q2 2022 | $16,000 | -5.9% | 8,045 | +32.4% | 0.00% | – |
| Q1 2022 | $17,000 | -19.0% | 6,074 | +41.1% | 0.00% | – |
| Q4 2021 | $21,000 | +133.3% | 4,305 | +526.6% | 0.00% | – |
| Q3 2021 | $9,000 | -64.0% | 687 | -57.8% | 0.00% | -100.0% |
| Q2 2021 | $25,000 | -28.6% | 1,628 | +54.3% | 0.00% | 0.0% |
| Q1 2021 | $35,000 | – | 1,055 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $23,927,000 | 8.46% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $14,762,000 | 4.72% |
| Novo Holdings A/S | 4,503,991 | $56,975,000 | 2.95% |
| Vivo Capital, LLC | 3,871,291 | $48,972,000 | 2.20% |
| Sofinnova Investments, Inc. | 2,754,437 | $34,844,000 | 2.06% |
| Samsara BioCapital, LLC | 737,459 | $9,329,000 | 1.46% |
| Ally Bridge Group (NY) LLC | 257,267 | $3,254,000 | 0.96% |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $9,102,000 | 0.68% |
| Rock Springs Capital Management LP | 1,649,248 | $20,863,000 | 0.44% |
| RA Capital Management | 2,378,325 | $30,086,000 | 0.42% |